Received Aug 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | — | — |
Active ingredient not added to diluent; Administration over the recommended age; Inappropriate age at vaccine administration; Extra dose administered; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 31-year-old male patient who received MMR (Priorix) for prophylaxis. Previously administered products included Priorix (received 2 doses on an unknown date). On an unknown date, the patient received the 3rd dose of Priorix. On an unknown date, an unknown time after receiving Priorix, the patient experienced inappropriate preparation of medication (Verbatim: Active ingredient not added to diluent), inappropriate dose of vaccine administered (Verbatim: Administration over the recommended age), inappropriate age at vaccine administration (Verbatim: Inappropriate age at vaccine administration) and extra dose administered (Verbatim: Extra dose administered). The outcome of the inappropriate preparation of medication, inappropriate dose of vaccine administered, inappropriate age at vaccine administration and extra dose administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: The pharmacist reported that the possible administration of Priorix vaccine with received only the diluent portion of the vaccine, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The patient received 3 doses of Priorix vaccine, which led to extra dose administered The patient received dose of Priorix vaccine at an inappropriate age, which led to inappropriate age at vaccine administration. The vaccine administration facility was the same as primary reporter.